Receptor (n = 21)
|
NCBI accession number
|
Novel alternative splice variants
|
---|
VEGFR1
|
NM_002019
|
2
|
VEGFR2
|
NM_002253
|
1
|
VEGFR3
|
NM_002020
|
3
|
Met
|
NM_000246
|
15
|
Ron
|
NM_002447
|
4
|
Tie1
|
NM_005424
|
5
|
Tie2
|
NM_000459
|
2
|
CSF1R
|
NM_005211
|
1
|
Kit
|
NM_000222
|
1
|
PDGFRβ
|
NM_002609
|
1
|
FGFR1
|
M34641
|
2
|
FGFR2
|
NM_000141
|
4
|
FGFR4
|
NM_002011
|
2
|
EPHA1
|
NM_005232
|
2
|
EPHA2
|
NM_004431
|
1
|
EPHB1
|
NM_004441
|
1
|
EPHB4
|
NM_004444
|
3
|
IGFR1
|
NM_000875
|
2
|
DDR1
|
NM_013993
|
2
|
TNFR1β
|
NM_001066
|
1
|
RAGE
|
NP_001127
|
5
|
Total
| |
60
|
- Sixty novel alternative splice variants were cloned from 21 cell surface receptor genes by RT-PCR amplification followed by extensive colony screening. The number of novel alternative splice variants is presented for each receptor tested. NCBI, National Center for Biotechnology Information.